image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
SC 13G
Filing Date
February 13, 2023
Document Date
February 13, 2023
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC
Print Page
RSS Feeds
Email Alerts
Search